CTRI/2026/07/113518进行中（未招募）不适用
The objective of this study is to evaluate the in-vivo safety and efficacy of skin care formulations in terms of reduction in under eye dark circles, pigmentation and fine lines on healthy human participants - Nil
SLJ Solution Logistics LLP0 个研究点目标入组 30 人开始时间: —最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Indian Female participants
- •2.Healthy subjects
- •3.Skin is healthy on the studied anatomic unit
- •4.Having mild to moderate dark circles.
- •5.Having fine lines
排除标准
- •1.Being pregnant or breastfeeding or having 2.stopped breastfeeding within the past three months
- •3.Refusing to provide assent by not signing the informed consent form
- •4.Taking part in another study that may interfere with this study
- •5.Being insulin dependent diabetic or non insulin dependent diabetic with recent therapy within the past six months
- •6.Having progressive asthma either under treatment or with an asthma attack within the past two years
- •7.Having a chronic skin disease that may modify skin reactivity in the test area except in studies specifically conducted on that skin disease
- •8.Having unstable thyroid disease requiring treatment that has not been stable for at least six months
- •9.Being diagnosed with epilepsy
- •10.Receiving chronic medicinal treatment including aspirin based products anti inflammatory drugs antihistamines or corticosteroids administered by either general or local routes The only permitted medication is paracetamol
- •11.Having skin hypersensitivity
- •12.Having a diagnosed or highly probable allergy to one or more ingredients of the cosmetic products
- •13.Having undergone surgery requiring general anesthesia for more than one hour within the past six months
研究者
相似试验
进行中（未招募）
不适用
Study to check the safety and efficacy of cosmetic productCTRI/2026/07/113999Bajaj Consumer Care Ltd30
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, ChronicjRCT2031260364200